>
pdufa.bio

fasedienol

Updated ยทnext FDA decision on the calendar

fasedienol is a Vistagen Therapeutics, Inc. program. Its next catalyst is a Readout in Q3 2026. Every date links its source.

VTGN catalyst hub

All upcoming FDA decision dates on the 2026 PDUFA calendar

About this program

Sponsor: Vistagen Therapeutics, Inc. (VTGN). We track 1 catalyst event for this program: 1 upcoming and 0 in the record. A PDUFA date is the FDA's target date to complete review of a marketing application; a readout is the sponsor's expected date for clinical trial results. What a PDUFA date is · why we do not compare trial results across drugs.

Catalyst history

Readout · Q3 2026VTGN

Questions

When is fasedienol's next FDA decision or readout?

The next tracked catalyst for fasedienol is a Readout in Q3 2026.

What happened at fasedienol's most recent FDA decision?

No FDA decision for fasedienol is in our archive yet.

Who makes fasedienol?

Vistagen Therapeutics, Inc. (VTGN).

Where does this data come from?

FDA announcements, sponsor press releases and SEC filings; every date on this page links its source.